T-Therapeutics

T-Therapeutics is a biotechnology company developing next-generation TCR therapies aimed at reshaping the clinical landscape for cancer patients. The company was founded to harness the power of T-cell biology, which has evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases. T-Therapeutics combines world-leading expertise in mouse genome engineering, biopharmaceutical drug development, single-cell genomics, machine learning, and structural biology, built on a foundation of creativity and a collaborative culture.